制药巨头密集在美建厂,背后有哪些驱动因素

第一财经
06 Dec 2024

当地时间12月5日,礼来宣布将投资30亿美元扩建其在美国威斯康星州于今年早些时候收购的一座制造工厂,以满足减重和糖尿病药物不断增长的需求。近一个月来,已有多家制药巨头宣布在美国大规模投资药物生产基地,背后的驱动因素也不尽相同。礼来位于威斯康星州的新工厂也是该公司位于美国印第安纳州以外最大的美国制造业投资,新工厂预计将于2025年底投产。礼来曾表示,尽管短期内减重和糖尿病药物的供应仍然有限,但随着...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10